Common Sensing Overview

  • Founded

  • 2012

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 27

Employees
  • Latest Deal Type

  • M&A

Common Sensing General Information

Description

Developer of a smart cap for insulin pens designed to generate an insulin logbook that can be shared with care providers and families. The company's product is a hardware and software-based medical device that acts as a personal insulin assistant for recording a user's insulin intake information and transmits the data to mobile phones or glucose meters, enabling diabetic patients to improve access to care, reduce healthcare costs and improve health outcomes.

Contact Information

Website
www.common-sensing.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Acquirer
Bigfoot Biomedical
Primary Office
  • 288 Norfolk Street
  • Suite 2B
  • Cambridge, MA 02139
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Common Sensing Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 14-Jun-2021 000.00 Completed Generating Revenue
7. Equity Crowdfunding 01-Nov-2020 Cancelled Generating Revenue
6. Later Stage VC 09-Nov-2020 00.000 000.00 Completed Generating Revenue
5. Debt - PPP 03-May-2020 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 29-Mar-2018 00.000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC 16-Jun-2016 00.000 00.000 Completed Startup
2. Seed Round 08-Sep-2015 $1.41M $2.93M 00.000 Completed Startup
1. Seed Round 16-Sep-2014 $1.52M $1.52M 00.000 Completed Startup
To view Common Sensing’s complete valuation and funding history, request access »

Common Sensing Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series AA 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Common Sensing’s complete cap table history, request access »

Common Sensing Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a smart cap for insulin pens designed to generate an insulin logbook that can be shared with care providers
Monitoring Equipment
Cambridge, MA
27 As of 2020
000.00
000000&0 000.00

00000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000000000 000000000
New Delhi, India
000 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

e velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000000000 000000000
New York, NY
0 As of 0000
000.00
0.00 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Common Sensing Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BeatO Venture Capital-Backed New Delhi, India 000 000.00 0000000000 0 000.00
000000 000000 Formerly VC-backed New York, NY 0 000.00 000000&0 000.00
000000000 Formerly Accelerator/Incubator backed London, United Kingdom 00 000000&0
0000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
00000000 00000000 Private Equity-Backed Basel, Switzerland 0000 000000000000
You’re viewing 5 of 37 competitors. Get the full list »

Common Sensing Patents

  • 11

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Common Sensing Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3029651-A1 Dose measurement systems and methods Pending 15-Jul-2016 00000000000
EP-3485237-A1 Dose measurement systems and methods Pending 15-Jul-2016 00000000000
EP-3485237-A4 Dose measurement systems and methods Pending 15-Jul-2016 00000000000 0
JP-2020062420-A Dose measurement system and method Pending 15-Jul-2016 00000000000
US-10695501-B2 Dose measurement systems and methods Active 15-Jul-2016 A61M5/31535
To view Common Sensing’s complete patent history, request access »

Common Sensing Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Common Sensing Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Emma Fiszman Angel (individual) Minority 000 0000 000000 0
Han Shu Angel (individual) Minority 000 0000 000000 0
Haselmeier Other Minority 000 0000 000000 0
Jonathan Greenfield Angel (individual) Minority 000 0000 000000 0
Joseph Oved Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial